CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: parecoxib
Accession: CHEBI:73038
browse the term
Definition: An N-acylsulfonamide resulting from the formal condensation of valdecoxib with propionic acid. It is a prodrug for valdecoxib.
Synonyms: exact_synonym: N-{[4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)phenyl]sulfonyl}propanamide
related_synonym: Formula=C19H18N2O4S; InChI=1S/C19H18N2O4S/c1-3-17(22)21-26(23,24)16-11-9-14(10-12-16)18-13(2)25-20-19(18)15-7-5-4-6-8-15/h4-12H,3H2,1-2H3,(H,21,22); InChIKey=TZRHLKRLEZJVIJ-UHFFFAOYSA-N; N-((p-(5-methyl-3-phenyl-4-isoxazolyl)phenyl)sulfonyl)propionamide; SC-69124; SMILES=CCC(=O)NS(=O)(=O)c1ccc(cc1)-c1c(C)onc1-c1ccccc1; parecoxibum
xref: CAS:198470-84-7; Drug_Central:2063; KEGG:D02709; LINCS:LSM-5316
xref_mesh: MESH:C409945
xref: PDBeChem:PXB; Reaxys:8640266; Wikipedia:Parecoxib
G
CDH1
cadherin 1
increases expression
EXP
parecoxib results in increased expression of CDH1 protein
CTD
PMID:35917206
NCBI chr16:68,737,292...68,835,537
Ensembl chr16:68,737,292...68,835,537
G
CNR1
cannabinoid receptor 1
increases response to substance
ISO
CNR1 protein results in increased susceptibility to parecoxib
CTD
PMID:23371449
NCBI chr 6:88,139,864...88,167,349
Ensembl chr 6:88,139,864...88,166,347
G
CTNNB1
catenin beta 1
decreases expression
EXP
parecoxib results in decreased expression of CTNNB1 protein
CTD
PMID:35917206
NCBI chr 3:41,199,505...41,240,443
Ensembl chr 3:41,194,741...41,260,096
G
GSK3B
glycogen synthase kinase 3 beta
increases expression decreases expression
EXP
parecoxib results in increased expression of GSK3B protein parecoxib results in decreased expression of GSK3B protein modified form
CTD
PMID:35917206
NCBI chr 3:119,821,321...120,094,447
Ensembl chr 3:119,821,321...120,094,994
G
MACC1
MET transcriptional regulator MACC1
decreases expression
EXP
parecoxib results in decreased expression of MACC1 protein
CTD
PMID:35917206
NCBI chr 7:20,134,655...20,217,384
Ensembl chr 7:20,134,655...20,217,404
G
MAPK1
mitogen-activated protein kinase 1
decreases phosphorylation
EXP
parecoxib results in decreased phosphorylation of MAPK1 protein
CTD
PMID:35917206
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
G
MAPK3
mitogen-activated protein kinase 3
decreases phosphorylation
EXP
parecoxib results in decreased phosphorylation of MAPK3 protein
CTD
PMID:35917206
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
G
MAPK8
mitogen-activated protein kinase 8
increases phosphorylation
EXP
parecoxib results in increased phosphorylation of MAPK8 protein
CTD
PMID:35917206
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MAPK9
mitogen-activated protein kinase 9
increases phosphorylation
EXP
parecoxib results in increased phosphorylation of MAPK9 protein
CTD
PMID:35917206
NCBI chr 5:180,233,143...180,292,083
Ensembl chr 5:180,233,143...180,292,099
G
MET
MET proto-oncogene, receptor tyrosine kinase
decreases expression
EXP
parecoxib results in decreased expression of MET protein
CTD
PMID:35917206
NCBI chr 7:116,672,196...116,798,377
Ensembl chr 7:116,672,196...116,798,377
G
VIM
vimentin
decreases expression
EXP
parecoxib results in decreased expression of VIM protein
CTD
PMID:35917206
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all